Skip to main content
VCbacked
Log inGet Started

IbisVision

Newhouse, United Kingdom

IbisVision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma.

$5.6M raised
May 2023
Venture - Series Unknown
Health CareLife ScienceMedical Device

Top Investors

Scottish EnterpriseDeepbridge CapitalApollo Informal InvestmentCompiler Venture CapitalSBRI Healthcare

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about IbisVision

How much funding has IbisVision raised?
IbisVision has raised $5.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
Who are IbisVision's investors?
IbisVision's investors include Scottish Enterprise, Deepbridge Capital, Apollo Informal Investment, Compiler Venture Capital, SBRI Healthcare.
Where is IbisVision headquartered?
IbisVision is headquartered in Newhouse, United Kingdom.
What does IbisVision do?
IbisVision has developed ‘Ring of Sight’ (ROS), a unique eye test that is specifically designed for the early detection of glaucoma.
What stage is IbisVision at?
IbisVision is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"IbisVision — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/ibisvision. Accessed July 2, 2026.
APA
VCBacked. (2023). IbisVision — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ibisvision
Wikipedia (cite web)
{{cite web |title=IbisVision — Funding & Investors |url=https://www.vcbacked.co/company/ibisvision |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Rapport Therapeutics
Boston$250.0M
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
YLAH
Bern$589K
Novostia
Epalinges$6.6M